In Brief: Sherwood-Davis & Geck/Mead Johnson Nutritionals
This article was originally published in The Gray Sheet
Executive Summary
Sherwood-Davis & Geck/Mead Johnson Nutritionals: Companies enter agreement to co-market enteral nutritional formula products and devices in the U.S. Under the pact, American Home Products division Sherwood-Davis & Geck will serve as the sales agent for Mead Johnson's line of medical nutritionals -- including the Sustacal, Isocal, and Ultracal brands -- in the alternate site market, where it will sell the products alongside its Kangaroo pumps and Dobbhoff and Entriflex enteral access devices. The two companies will "cooperatively market" their products in the acute care market. Mead Johnson will continue to independently sell its products in the retail consumer market...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.